CLL Topics Banner: Therapies, Research and Patient Education for Chronic Lymphocytic Leukemia
CLL Topics Home Navigation Topics Alert Learning Tools About Us Feedback Feedback
Full Menu

Topics Alert

world balloon

Topics Alert Archive

Alert Number 120

Dr. Faderl's Response

  — and Comments from Us and Professor Terry Hamblin

Date: August 12, 2005

We are pleased to report that Dr. Stefan Faderl, the principal investigator at M. D. Anderson Cancer Center for the FCR+M and Neulasta clinical trial, has responded to our letter and the review of the clinical trial we published yesterday. As promised, his detailed and thoughtful response to the troubling questions we raised is published on our website, together with an exchange of emails specifically on the subject of cardiac toxicity. You can read this part of the saga in More on Mitoxantrone plus FCR. This is “must read” material if you are thinking of participating in this or for that matter any other clinical trial.

There is a great deal of common ground between patients looking for better therapy options and researchers who spend their lives looking for better answers. The process works a whole lot better when patient groups are given a voice in the way clinical trials are conducted. The developments of the past few days underline, once more, the need for patient participation in Institutional Review Boards.

Be well,


NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.

Go to Alert Archive Listing

You may also retrieve a different Alert,
by entering a new Alert number here
(in the range 1 to 309)



Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.

Copyright Notice:

Copyright © 2002-2007 CLL Topics, Inc. All Rights Reserved.

All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.

However, you may download and print material from exclusively for your personal, noncommercial use.




up arrow